ADVATE-PASS: postmarketing safety follow-up of Advate rAHF-PFM in patients with hemophilia A
DEC-NET Serial number ES450
Published online22/07/2005 10.46.00
Last updated24/04/2006 8.47.23
Other protocol ID number
Current trial statusOpen (actively recruiting new participants)
Major Disease
(ICD9 class)		CONGENITAL FACTOR VIII DISORDER (haemophilia)
Gender
Age (range)

Eligibility criteria

Trial design/methodology
Phase
Kind of study
DesignControlled
Principal investigator
NameCarmen Altisent
InstitutionHospital Universitari Vall d'Hebron; Unidad de Hemofilia.
Postal addressPasseig Vall d'Hebron, 119-129
CityBarcelona, 08035
CountrySPAIN
Phone934272000
Fax
E-mail

ISRCTN  EudraCT